Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Guertin

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Nature|July 1, 2018
Unexpected cell population gives fat a brakeDavid A Guertin
Current Diabetes Reports|November 22, 2019
De Novo Lipogenesis as a Source of Second Messengers in AdipocytesWen-Yu Hsiao, David A Guertin
Nature Reviews. Cancer|January 19, 2023
Acetyl-CoA metabolism in cancerDavid A Guertin, Kathryn E Wellen
Trends in Molecular Medicine|July 9, 2005
An expanding role for mTOR in cancerDavid A Guertin, David M Sabatini
Cancer Cell|July 7, 2007
Defining the role of mTOR in cancerDavid A Guertin, David M Sabatini
Cancer Cell|December 18, 2014
mTORC1 gRABs the GolgiJoan Sanchez-Gurmaches, David A Guertin
Nature Metabolism|July 15, 2024
Adipose glutaminolysis resurfaces in metabolic diseaseJohn A Haley, David A Guertin
Molecular Cell|December 22, 2018
Insulin PACS a Punch in SIRT1 ActivitySu Myung Jung, David A Guertin
Science Signaling|April 23, 2009
The pharmacology of mTOR inhibitionDavid A Guertin, David M Sabatini
Nature Cell Biology|January 30, 2019
Oncogenic AKTivation by methylationAmelia K Luciano, David A Guertin
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Nature|July 1, 2018
Unexpected cell population gives fat a brakeDavid A Guertin
Current Diabetes Reports|November 22, 2019
De Novo Lipogenesis as a Source of Second Messengers in AdipocytesWen-Yu Hsiao, David A Guertin
Nature Reviews. Cancer|January 19, 2023
Acetyl-CoA metabolism in cancerDavid A Guertin, Kathryn E Wellen
Trends in Molecular Medicine|July 9, 2005
An expanding role for mTOR in cancerDavid A Guertin, David M Sabatini
Cancer Cell|July 7, 2007
Defining the role of mTOR in cancerDavid A Guertin, David M Sabatini
Cancer Cell|December 18, 2014
mTORC1 gRABs the GolgiJoan Sanchez-Gurmaches, David A Guertin
Nature Metabolism|July 15, 2024
Adipose glutaminolysis resurfaces in metabolic diseaseJohn A Haley, David A Guertin
Molecular Cell|December 22, 2018
Insulin PACS a Punch in SIRT1 ActivitySu Myung Jung, David A Guertin
Science Signaling|April 23, 2009
The pharmacology of mTOR inhibitionDavid A Guertin, David M Sabatini
Nature Cell Biology|January 30, 2019
Oncogenic AKTivation by methylationAmelia K Luciano, David A Guertin
Pageof 7